Sohei Harada
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
- Vibrio bacteria research studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 10
- Amoebic Infections and Treatments 8
- COVID-19 Clinical Research Studies 7
- Epidemiology 31
- Mycobacterium research and diagnosis 11
- Infective Endocarditis Diagnosis and Management 7
- Co-authors
- Yoshikazu Ishii (14 shared papers)Kazuhiro Tateda (15 shared papers)Yohei Doi (13 shared papers)Tomoo Saga (9 shared papers)Keizo Yamaguchi (6 shared papers)Koh Okamoto (30 shared papers)Kotaro Aoki (13 shared papers)Kyoji Moriya (24 shared papers)
- Journals
- Microbiology Spectrum (6 papers)International Journal of Infectious Diseases (4 papers)BMC Infectious Diseases (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Clinical Microbiology (4 papers)
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Sohei Harada
69 papers receiving 928 citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 507
- Endocrinology 235
- Applied Microbiology and Biotechnology 71
- Clinical Biochemistry 114
- Infectious Diseases 264
Countries citing papers authored by Sohei Harada
This map shows the geographic impact of Sohei Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sohei Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sohei Harada more than expected).
Fields of papers citing papers by Sohei Harada
This network shows the impact of papers produced by Sohei Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sohei Harada. The network helps show where Sohei Harada may publish in the future.
Co-authors
The 25 scholars most cited alongside Sohei Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 68 | |
| 2 | 2012 | 57 | |
| 3 | 2018 | 54 | |
| 4 | 2010 | 52 | |
| 5 | 2012 | 52 | |
| 6 | 2011 | 35 | |
| 7 | 2008 | 34 | |
| 8 | 2011 | 34 | |
| 9 | 2021 | 32 | |
| 10 | 2011 | 30 | |
| 11 | 2018 | 28 | |
| 12 | 2012 | 24 | |
| 13 | 2012 | 23 | |
| 14 | 2015 | 23 | |
| 15 | 2014 | 23 | |
| 16 | 1987 | 23 | |
| 17 | 2013 | 21 | |
| 18 | 2017 | 20 | |
| 19 | 2021 | 18 | |
| 20 | 2020 | 18 |
About Sohei Harada
Sohei Harada is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 81 papers that have together received 943 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (28 papers), Bacterial Identification and Susceptibility Testing (13 papers), Mycobacterium research and diagnosis (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Amoebic Infections and Treatments (8 papers), Infective Endocarditis Diagnosis and Management (7 papers), COVID-19 Clinical Research Studies (7 papers) and Streptococcal Infections and Treatments (7 papers). The work is most often cited by research in Molecular Medicine (507 citations), Endocrinology (235 citations), Applied Microbiology and Biotechnology (71 citations), Clinical Biochemistry (114 citations) and Infectious Diseases (264 citations). Sohei Harada has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Yoshikazu Ishii, Kazuhiro Tateda, Yohei Doi, Tomoo Saga, Keizo Yamaguchi, Koh Okamoto, Kotaro Aoki, Kyoji Moriya, Yoshikazu Ishii and Toshihiko Shimada. Their work appears in journals such as Microbiology Spectrum, International Journal of Infectious Diseases, BMC Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.